Akers Biosciences (AKER) Issues Update on Chinese Joint Venture: Savy Akers
Tweet Send to a Friend
Akers Biosciences (Nasdaq: AKER) announces an update on the progress of its 19.9%-owned Chinese joint venture company, Hainan Savy Akers ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
